Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Purple Biotech stock

Learn how to easily invest in Purple Biotech stock.

Purple Biotech is a biotechnology business based in the US. Purple Biotech shares (PPBT) are listed on the NASDAQ and all prices are listed in US Dollars. Purple Biotech employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Purple Biotech

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PPBT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Purple Biotech stock price (NASDAQ: PPBT)

Use our graph to track the performance of PPBT stocks over time.

Purple Biotech shares at a glance

Information last updated 2022-10-02.
Latest market close$2.14
52-week range$1.83 - $4.75
50-day moving average $2.34
200-day moving average $2.92
Wall St. target price$25.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.08

Buy Purple Biotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Purple Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Purple Biotech price performance over time

Historical closes compared with the close of $2.1401 from 2022-10-03

1 week (2022-09-27) 12.64%
1 month (2022-09-02) -8.15%
3 months (2022-07-01) -1.38%
6 months (2022-04-04) -45.82%
1 year (2021-10-04) -50.92%
2 years (2020-10-02) -50.58%
3 years (2019-10-04) 2,780.35%
5 years (2017-10-04) 1,026.37%

Purple Biotech financials

Gross profit TTM $-55,000
Return on assets TTM -16.9%
Return on equity TTM -29.14%
Profit margin 0%
Book value $3.08
Market capitalisation $37.2 million

TTM: trailing 12 months

Purple Biotech share dividends

We're not expecting Purple Biotech to pay a dividend over the next 12 months.

Have Purple Biotech's shares ever split?

Purple Biotech's shares were split on a 1:10 basis on 21 August 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Purple Biotech shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Purple Biotech shares which in turn could have impacted Purple Biotech's share price.

Purple Biotech share price volatility

Over the last 12 months, Purple Biotech's shares have ranged in value from as little as $1.833 up to $4.75. A popular way to gauge a stock's volatility is its "beta".

PPBT.US volatility(beta: 1.98)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Purple Biotech's is 1.976. This would suggest that Purple Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Purple Biotech overview

Purple Biotech Ltd. , a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel. .

Frequently asked questions

What percentage of Purple Biotech is owned by institutions?
Currently 0.735% of Purple Biotech shares are held by institutions.
How many people work for Purple Biotech?
Latest data suggests 19 work at Purple Biotech.
When does the fiscal year end for Purple Biotech?
Purple Biotech's fiscal year ends in December.
Where is Purple Biotech based?
Purple Biotech's address is: 4 Oppenheimer Street, Rehovot, Israel, 7670104
What is Purple Biotech's ISIN number?
Purple Biotech's international securities identification number is: US74638P1093

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site